Smoking cessation in schizophrenia: A double blind placebo controlled trial of bupropion SR added to cognitive behavioral therapy

被引：0
|
作者：
Evins, AE
Cather, C
Culhane, M
Freudenreich, O
Rigotti, NA
Goff, DC
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
来源：
BIOLOGICAL PSYCHIATRY | 2004年 / 55卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
806
引用
收藏
页码：226S / 226S
页数：1
相关论文
共 50 条
  • [1] A placebo controlled trial of bupropion for smoking cessation in schizophrenia
    George, TP
    Vessicchio, JC
    Termine, A
    Bregartner, TA
    Feingold, A
    Rounsaville, BJ
    Kosten, TR
    [J]. BIOLOGICAL PSYCHIATRY, 2002, 52 (01) : 53 - 61
  • [2] A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia
    Evins, AE
    Cather, C
    Deckersbach, T
    Freudenreich, O
    Culhane, MA
    Olm-Shipman, CM
    Henderson, DC
    Schoenfeld, DA
    Goff, DC
    Rigotti, NA
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (03) : 218 - 225
  • [3] A comparison of bupropion SR and placebo for smoking cessation in schizophrenia
    Weiner, E
    Buchanan, R
    Gold, J
    Ball, P
    Bennett, M
    [J]. SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 305 - 306
  • [4] A double blind placebo controlled trial of bupropion added to nicotine patch and cognitive behavioral therapy in smokers with current or past unipolar depressive disorder
    Evins, AE
    Alpert, JE
    Pava, J
    Petersen, TJ
    Farabaugh, AH
    Fava, M
    [J]. NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S91 - S91
  • [5] Bupropion and naltrexone for smoking cessation: A double-blind randomized placebo-controlled clinical trial
    Mooney, M. E.
    Schmitz, J. M.
    Allen, S.
    Grabowski, J.
    Pentel, P.
    Oliver, A.
    Hatsukami, D. K.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (04) : 344 - 352
  • [6] A double-blind, placebo-controlled, Randomized trial of Bupropion for smoking cessation in primary care
    Fossati, Roldano
    Apolone, Giovanni
    Negri, Emanuele
    Compagnoni, Anna
    La Vecchia, Carlo
    Mangano, Simone
    Clivio, Luca
    Garattini, Silvio
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (16) : 1791 - 1797
  • [7] A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia
    Evins, A. Eden
    Cather, Corinne
    Culhane, Melissa A.
    Birnbaum, Alan
    Horowitz, Jonathan
    Hsieh, Elaine
    Freudenreich, Oliver
    Henderson, David C.
    Schoenfeld, David A.
    Rigotti, Nancy A.
    Goff, Donald C.
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (04) : 380 - 386
  • [8] A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia
    Fatemi, SH
    Stary, JM
    Hatsukami, DK
    Murphy, SE
    [J]. SCHIZOPHRENIA RESEARCH, 2005, 76 (2-3) : 353 - 356
  • [9] A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia
    George, Tony P.
    Vessicchio, Jennifer C.
    Sacco, Kristi A.
    Weinberger, Andrea H.
    Duclas, Melissa M.
    Allen, Taryn M.
    Creeden, Cerissa L.
    Potenza, Marc N.
    Feingold, Alan
    Jatlow, Peter I.
    [J]. BIOLOGICAL PSYCHIATRY, 2008, 63 (11) : 1092 - 1096
  • [10] Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling
    Collins, BN
    Wileyto, EP
    Patterson, F
    Rukstalis, M
    Audrain-McGovern, J
    Kaufmann, V
    Pinto, A
    Hawk, L
    Niaura, R
    Epstein, LH
    Lerman, C
    [J]. NICOTINE & TOBACCO RESEARCH, 2004, 6 (01) : 27 - +
12345